预测使用胃精度测量对原蛋白治疗的症状反应
Chris Varghese1,2, Sibylle Van Hove3, Gabriel Schamberg1,3
1Department of Surgery, University of Auckland, Auckland, New Zealand.
Neurogastroenterology and motility
|July 30, 2025
概括
身体表面胃映射 (BSGM) 生物标志物可以预测慢性神经胃关节疾病中的 prokinetic 治疗反应. 较低的食后振幅表明有好处,而不良的节律稳定性表明更糟糕的结果.
科学领域:
- 胃肠病学 胃肠病学
- 生物标志物发现发现
- 神经胃肠病学 神经胃肠病学
背景情况:
- 慢性神经胃关节疾病带来了管理挑战,通常依赖于经验性 prokinetic 疗法.
- 诱导性疗效是可变的,并与不良事件相关,限制了它们的使用.
- 调查用于个性化 prokinetic 选择的新生物标志物至关重要.
研究的目的:
- 评估身体表面胃映射 (BSGM) 生物标志物,以预测 prokinetic 治疗反应.
- 为了确定胃精度能否指导患有胃腹部症状的患者的发动性选择.
主要方法:
- 预期招募患有慢性胃肠关节症状的患者使用 prokinetic 药物.
- 身体表面胃映射 (BSGM) 执行了与标准化餐一起的非蛋白质性药物.
- 用于评估结果的症状日记和临床反应定义.
主要成果:
- 在原始动力学患者中,较低的食后幅度预测了对原始动力学治疗的积极反应 (p=0.047).
- 在已经接受 prokinetics 的患者中,较低的幅度与减少的症状负担相关.
- 胃节律稳定性受损预测,在现有前体动力学 (p<0.05) 的患者中,症状负担会更严重.
结论:
- 胃度生物标志物显示出预测胃管关节疾病的原动力反应的潜力.
- 较低的食后幅度可能表明患者可能从 prokinetic 治疗中受益.
- 节律稳定性受损表明对 prokinetics 的治疗反应较差.
相关概念视频
Gastric Emptying
1.4K
Gastric emptying occurs when the stomach gradually releases chyme into the duodenum. When the stomach is distended, it triggers the release of gastrin, a hormone that promotes gastric acid secretion to aid in digestion. Additionally, stomach distension contributes to peristaltic waves that propel gastric contents toward the pyloric region. The gastroenteric reflex, on the other hand, primarily stimulates peristalsis in the intestines, facilitating the movement of contents further along the...
1.4K
Gastric Motility
1.2K
Gastric motility is the coordinated contraction and relaxation of stomach muscles that convert ingested food into chyme, a semi-liquid substance ready for further digestion in the intestines. The process begins with the vagus nerve inducing the relaxation of the smooth muscles in the fundus and body of the stomach, allowing these regions to expand and accommodate up to approximately 1.5 liters of food and liquid.
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
1.2K
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
622
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
622
Gastrointestinal Motility Disorders
599
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
599
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
144
This lesson explores three gastrointestinal imaging techniques: radionuclide testing, colonic transit studies, and virtual colonoscopy.
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
144
Gastroesophageal Reflux Disease II: Clinical Features and Management
216
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
216


